MDMA prescriptions to become FDA approved

MDMA prescriptions to become FDA approved

MDMA prescriptions could be soon be a thing as the FDA approves phase three trials. The trials focus on using MDMA prescriptions to treat PTSD (Post Traumatic Stress Disorder).

This phase is the final step before it will be scheduled as a prescription medicine in the USA. And as history shows, when the USA changes policies the world tends to follow.

In 2015 they carried out phase two of the trials, this was sponsored by Multidisciplinary Association for Psychedelic Studies (MAPS). They treated one hundred and thirty sexual assault victims, fire fighters, veterans, and police officers who all suffer from PTSD.

“I’m cautious but hopeful. If they can keep getting good results, it will be of great use. PTSD can be very hard to treat. Our best therapies right now don’t help 30 to 40 percent of people. So we need more options,” said Dr. Charles R. Marmar, head of psychiatry at New York University’s Langone School of Medicine, to the New York Times

<h4> It’s not about rushing your brains off…

The patients in the study aren’t just given MDMA prescriptions and left to rush their brains out. They are also given twelve weeks of therapy, and these are combined with three eight hour MDMA sessions.

It’s all very professional, they lay down in a room that has fresh flowers, candles, and soft background music.

The objective of the sessions is to help the sufferers work through their memories of trauma. The MDMA therapy is managed by Dr. Michael C. Mithoefer and his wife, Ann Mithoefer,

Led by Dr. Michael C. Mithoefer and his wife, Ann Mithoefer, for the sessions they sat with the patients helping them work through their memories that cause PTSD.

The final phase of this trial will take place next year with as many as two hundred and thirty  PTSD sufferers taking part. If phase three goes well then Americans could be filling out MDMA prescriptions at their local pharmacies by 2021.